In 1986, Congress passed the Anti-Drug Abuse Act, establishing mandatory minimum sentences for federal drug offenses. The statute's most consequential provision — the 100-to-1 crack/powder cocaine sentencing disparity — would, over the following decades, send hundreds of thousands of Black Americans to federal prison for conduct that would have produced dramatically shorter sentences, or no incarceration at all, if committed by white Americans with powder cocaine.
The disparity was not, in any meaningful sense, an accident. It was the product of political decisions made in a specific racial and political context, sustained by institutional inertia, and defended by ideological commitments that proved far more durable than the evidence warranted.
Understanding drug sentencing disparities requires attending to three levels of analysis: the formal legal mechanisms that produce them, the political choices that created and maintained those mechanisms, and the broader ideological commitments that have made reform so difficult.
The Legal Architecture of Disparity
The most important structural feature of federal drug sentencing is the mandatory minimum statute. Mandatory minimums remove judicial discretion: once a defendant is convicted of a triggering offense, the judge must impose at least the minimum sentence specified by statute, regardless of individual circumstances.
In the drug context, mandatory minimums are typically triggered by drug quantity. The 1986 Act established five-year minimums for possession of five grams of crack cocaine or 500 grams of powder cocaine — the 100-to-1 disparity. Quantities sufficient to trigger ten-year minimums were set at 50 grams of crack or 5,000 grams of powder.
The racial consequences were immediate and dramatic. Because crack cocaine was associated with Black urban communities while powder cocaine was associated with white and Latino users, Black defendants were far more likely to face mandatory minimums and, consequently, far longer sentences than white defendants convicted of comparable conduct.
Federal Sentencing Commission data tell the story clearly: in the years following the 1986 Act, Black defendants constituted more than 80 percent of those convicted of federal crack cocaine offenses.
Prosecutorial Discretion as Amplifier
Mandatory minimums do not only determine sentences — they shift power from judges to prosecutors. Because mandatory minimums attach to charges rather than convictions, prosecutors who want to use a mandatory minimum can simply charge the relevant offense. Prosecutors who want to avoid one can charge a lesser or different offense.
This discretion has racial consequences. Research consistently shows that similarly situated Black defendants face more severe charges than white defendants, even controlling for relevant legal factors. Studies of federal drug prosecution have found that Black defendants are less likely to receive plea agreements that allow them to avoid mandatory minimums, less likely to receive substantial assistance departures, and more likely to receive guideline-range sentences without departure.
The Political Origins of Disparity
The 100-to-1 disparity was enacted in the context of the "crack epidemic" of the mid-1980s — a period of intense moral panic surrounding crack cocaine and its association with urban Black communities.
Congressional debates from 1986 reveal the rhetorical framework: crack was described as uniquely addictive, as destroying families, as producing violence. These claims were, as subsequent research established, substantially exaggerated. The pharmacological differences between crack and powder cocaine are modest; the social differences were constructed through racialized media coverage and political speech.
Critically, the 100-to-1 disparity was enacted without expert testimony, without hearings focused on its racial implications, and without evidence that it would be more effective than alternative approaches. It passed rapidly, as a symbolic gesture of congressional toughness, in a political environment in which the consequences — to Black communities, to the integrity of the legal system — were simply not a relevant consideration.
This origin story matters. The disparity was not the result of neutral policy analysis gone wrong; it was the result of political choices made in a context in which the welfare of the communities most affected was a low political priority.
The Long Struggle for Reform
Efforts to reform the crack/powder disparity began almost immediately after its enactment. The U.S. Sentencing Commission recommended reducing or eliminating the disparity multiple times beginning in the 1990s. Congress repeatedly rejected or ignored these recommendations.
The Fair Sentencing Act of 2010 reduced the disparity from 100-to-1 to 18-to-1 — a meaningful but still substantial gap. The First Step Act of 2018 made this change retroactive, allowing some people convicted under the old regime to seek resentencing.
These reforms were important. But they did not eliminate the disparity, and they left in place the broader architecture of mandatory minimums and prosecutorial discretion that continues to produce racial disparities across drug offenses.
Beyond the Disparity: Systemic Inequity
The crack/powder disparity is the most visible example of racial inequity in drug sentencing, but it is not the only one. A fuller accounting requires attention to:
Geographic variation: Drug sentencing varies substantially across federal districts, and this variation has racial dimensions. Districts with higher proportions of Black defendants tend to impose harsher sentences.
Substantial assistance departures: The primary mechanism for sentence reduction in the federal system — cooperation with prosecutors — is systematically less available to low-level, street-level defendants, who often have little information of value to offer. These defendants are disproportionately Black and Latino.
The trial penalty: Defendants who exercise their constitutional right to trial face substantially longer sentences than those who plead guilty. This differential has disproportionate effects on defendants who may have stronger claims of innocence but face such severe potential sentences that accepting a plea is rational regardless.
State systems: Federal drug sentencing receives disproportionate attention, but most drug prosecutions occur in state systems, where disparities are often more severe and less systematically studied.
What Would Genuine Reform Require?
Meaningful reform of drug sentencing disparities would require more than technical adjustments to sentencing guidelines. It would require:
Eliminating mandatory minimums for drug offenses, restoring judicial discretion and allowing sentences to be calibrated to individual circumstances.
Transparency in prosecutorial charging: Requiring prosecutors to document charging decisions and creating mechanisms to identify and address racial disparities in those decisions.
Retroactivity: Applying reforms retroactively to allow people serving unjust sentences to seek relief — a principle with strong moral force but persistent political resistance.
Investment in non-criminal responses: Recognizing that for many drug offenses, the criminal justice system is the wrong tool entirely, and that resources devoted to prosecution and incarceration would produce better public health outcomes if directed toward treatment and support.
None of these reforms is technically difficult. All of them are politically contested. The persistence of racial disparities in drug sentencing reflects not a failure of knowledge but a failure of political will — a continuing unwillingness to treat the harms imposed on Black communities by punitive drug enforcement as fully real, fully serious, and fully demanding of remedy.
Fahad Khan is a criminal justice scholar specializing in drug policy and sentencing. He holds an M.A. from the University of Mississippi and is an incoming PhD student.